| Literature DB >> 28235689 |
Caroline Mari Ramos Oda1, Renata Salgado Fernandes1, Sávia Caldeira de Araújo Lopes1, Mônica Cristina de Oliveira1, Valbert Nascimento Cardoso2, Daniel Moreira Santos3, Adriano Monteiro de Castro Pimenta3, Angelo Malachias4, Rogério Paniago4, Danyelle M Townsend5, Patrick M Colletti6, Domenico Rubello7, Ricardo José Alves1, André Luís Branco de Barros2, Elaine Amaral Leite8.
Abstract
The use of nanoparticles for diagnostic approaches leads to higher accumulation in the targeting tissue promoting a better signal-to-noise ratio and consequently, early tumor detection through scintigraphic techniques. Such approaches have inherent advantages, including the possibility of association with a variety of gamma-emitting radionuclides available, among them, Tecnethium-99m (99mTc). 99mTc is readily conjugated with nanoparticles using chelating agents, such as diethylenetriaminepentaacetic acid (DTPA). Leveraging this approach, we synthesized polymeric micelles (PM) consisting of 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)-2000] (DSPE-mPEG2000) functionalized with DTPA for radiolabeling with 99mTc. Micelles made up of DSPE-mPEG2000 and DSPE-PEG2000-DTPA had a mean diameter of ∼10nm, as measured by DLS and SAXS techniques, and a zeta potential of -2.7±1.1mV. Radiolabeled micelles exhibited high radiochemical yields and stability. In vivo assays indicated long blood circulation time (456.3min). High uptake in liver, spleen and kidneys was observed in the biodistribution and imaging studies on healthy and tumor-bearing mice. In addition, a high tumor-to-muscle ratio was detected, which increased over time, showing accumulation of the PM in the tumor region. These findings indicate that this system is a promising platform for simultaneous delivery of therapeutic agents and diagnostic probes.Entities:
Keywords: Characterization; Platform for tumor delivering; Polymeric micelles; Radiolabeling; Synthesis
Mesh:
Substances:
Year: 2017 PMID: 28235689 PMCID: PMC5553549 DOI: 10.1016/j.biopha.2017.01.144
Source DB: PubMed Journal: Biomed Pharmacother ISSN: 0753-3322 Impact factor: 6.529